COVID-19

Strategies seeking to increase COVID-19 vaccine and booster uptake in Black patients with rheumatic diseases should consider and offer responses for racial, ethnic and socioeconomic factors, according to researchers.

Among patients with stages 3-4 chronic kidney disease, a COVID-19 infection increased the odds of rapid kidney function decline during the pandemic, according to a study.

The NIH announced that it has launched phase 2 clinical trials that will evaluate potential treatments for long COVID conditions as part of its Researching COVID to Enhance Recovery, or RECOVER, initiative.

A large study in the United Kingdom revealed some “epidemiologic nuances” of COVID-19 in children, experts said.

August is National Immunization Awareness Month. To mark the occasion, we compiled a list of vaccine stories you may have missed in 2023.

Use of azithromycin was associated with acute heart failure among patients with a history of CVD hospitalized with SARS-CoV-2 infection compared with standard care, researchers in Europe reported.

Fifteen months following COVID-19 hospitalization, both ventilated and nonventilated patients displayed diaphragm muscle weakness, according to results published in American Journal of Respiratory and Critical Care Medicine.

Perceptions of dialysis care did not change for most patients during the COVID-19 crisis, but recently published data show other aspects of their lives may have been affected.

Individuals with COVID-19 living in neighborhoods with high walkability and bikeability and less air pollution experienced fewer hospitalizations vs. areas with low mobility and more pollution, according to results published in PLoS ONE.

Treatment with neutralizing monoclonal antibodies in COVID-19 outpatients resulted in fewer hospital admissions and deaths vs. no antibody treatment, according to results published in CHEST.